Alnylam Pharmaceuticals shares owned by Smith Group Asset Management
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Smith Group Asset Management
from 13F filings
Historical chart of Smith Group Asset Management investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by Smith Group Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals by Smith Group Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $770k | 2.8k | 275.03 |
More positions owned by Smith Group Asset Management
View all positions for Smith Group Asset Management